Table 1.

Clinical outcomes across IAT-AIS trials.

Trial	% mRS 0–2 (3 months)	Time to IAT (h)	% TIMI 2, 3
PROACT II	42.3a	4.5b	58
IMS I	43	3.05 ± 0.8b	56
IMS II	46	n/a	64
IMS III	40.8	3.5b	81d
SYNTHESIS	41.9	3.45c	n/a
SWIFT	37	4.9b	83
TREVO 2	39.9	4.7c	90
MR CLEAN	32.6	4.3c	58.7d
EXTEND-IA	71	3.5c	86d
ESCAPE	53	3.1c	72.4d

^aBarthel Index 9 and 10.

^bMean.

^cMedian.

^dTICI 2, 3 for M1 occlusion.